Bristol-Myers Squibb Company

Bristol-Myers Squibb Company is a global biopharmaceutical company committed to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. The company focuses on areas such as oncology, cardiovascular, immunoscience, and fibrosis.

Sustainability

Bristol-Myers Squibb is dedicated to sustainability and has implemented various initiatives to reduce its environmental impact. The company publishes an annual ESG (Environmental, Social, and Governance) report that outlines its efforts and progress in sustainability. Key highlights include:

• Commitment to reducing greenhouse gas emissions and achieving carbon neutrality by 2040.
• Implementation of energy-efficient technologies and renewable energy sources in its operations.
• Waste reduction programs aimed at minimizing landfill waste and promoting recycling.
• Water conservation initiatives to reduce water usage and improve water quality.
• Adherence to global sustainability standards and certifications, including ISO 14001 for environmental management systems.

For more detailed information on Bristol-Myers Squibb's sustainability efforts, please refer to their latest ESG report available on their official website.